212 related articles for article (PubMed ID: 30640382)
1. Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.
Huo J; Xu Y; Sheu T; Volk RJ; Shih YT
JAMA Intern Med; 2019 Mar; 179(3):324-332. PubMed ID: 30640382
[TBL] [Abstract][Full Text] [Related]
2. Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.
Nishi SPE; Zhou J; Okereke I; Kuo YF; Goodwin J
Chest; 2020 Feb; 157(2):427-434. PubMed ID: 31521671
[TBL] [Abstract][Full Text] [Related]
3. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial.
Iaccarino JM; Silvestri GA; Wiener RS
Chest; 2019 Nov; 156(5):965-971. PubMed ID: 31283920
[TBL] [Abstract][Full Text] [Related]
4. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.
Rendle KA; Saia CA; Vachani A; Burnett-Hartman AN; Doria-Rose VP; Beucker S; Neslund-Dudas C; Oshiro C; Kim RY; Elston-Lafata J; Honda SA; Ritzwoller D; Wainwright JV; Mitra N; Greenlee RT
Ann Intern Med; 2024 Jan; 177(1):18-28. PubMed ID: 38163370
[TBL] [Abstract][Full Text] [Related]
5. Procedural complications associated with invasive diagnostic procedures after lung cancer screening with low-dose computed tomography.
Yang S; Shih YT; Huo J; Mehta HJ; Wu Y; Salloum RG; Alvarado M; Zhang D; Braithwaite D; Guo Y; Bian J
Lung Cancer; 2022 Mar; 165():141-144. PubMed ID: 35124410
[TBL] [Abstract][Full Text] [Related]
6. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.
Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS
Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.
Rai A; Doria-Rose VP; Silvestri GA; Yabroff KR
J Natl Cancer Inst; 2019 Apr; 111(4):342-349. PubMed ID: 30698792
[TBL] [Abstract][Full Text] [Related]
8. Invasive Procedures and Associated Complications After Initial Lung Cancer Screening in a National Cohort of Veterans.
Núñez ER; Caverly TJ; Zhang S; Glickman ME; Qian SX; Boudreau JH; Miller DR; Wiener RS
Chest; 2022 Aug; 162(2):475-484. PubMed ID: 35231480
[TBL] [Abstract][Full Text] [Related]
9. Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan.
Yang SC; Lai CH; Kuo CW; Lin CC; Lai WW; Wang JD
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33921313
[TBL] [Abstract][Full Text] [Related]
10. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic invasive procedures in the diagnosis of primary lung cancer. Diagnostic value and complications].
Almind M; Faurschou P; Viskum K
Ugeskr Laeger; 1996 Dec; 159(1):37-40. PubMed ID: 9012072
[TBL] [Abstract][Full Text] [Related]
12. Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis.
Lokhandwala T; Bittoni MA; Dann RA; D'Souza AO; Johnson M; Nagy RJ; Lanman RB; Merritt RE; Carbone DP
Clin Lung Cancer; 2017 Jan; 18(1):e27-e34. PubMed ID: 27530054
[TBL] [Abstract][Full Text] [Related]
13. Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre.
Wu CH; Ku LE; Lin CY; Chung TJ; Liu HJ; Chao TH; Yang SC
BMJ Open; 2023 Mar; 13(3):e070647. PubMed ID: 36898750
[TBL] [Abstract][Full Text] [Related]
14. Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians.
Ersek JL; Eberth JM; McDonnell KK; Strayer SM; Sercy E; Cartmell KB; Friedman DB
Cancer; 2016 Aug; 122(15):2324-31. PubMed ID: 27294476
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening.
Morgan L; Choi H; Reid M; Khawaja A; Mazzone PJ
Ann Am Thorac Soc; 2017 Sep; 14(9):1450-1456. PubMed ID: 28421812
[TBL] [Abstract][Full Text] [Related]
16. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
[TBL] [Abstract][Full Text] [Related]
17. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
18. The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries.
Wood DE
JAMA Intern Med; 2014 Dec; 174(12):2016-8. PubMed ID: 25317992
[TBL] [Abstract][Full Text] [Related]
19. Financial Analysis of Free Lung Cancer Screening Program Shows Profitability Using Broader NCCN Guidelines.
Chung JM; Simmerman EL; Sadek RF; Wojtowicz S; Dillard TA; Albo D; Thomson NB; Schroeder C
Ann Thorac Surg; 2019 Mar; 107(3):885-890. PubMed ID: 30419190
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
